R. Mandhwani, “Use of sofosbuvir based regimen in patients with end-stage renal disease and chronic hepatitis C; an open label, non-randomized, single arm, single center study from Pakistan”, Gastroenterol Hepatol Bed Bench, vol. 13, no. 2, pp. 141–146, Mar. 2020.